Researchers have developed a new organoid that mimics the human fetal pancreas, offering a clearer view of its early development.

Kraig Biocraft Laboratories has developed transgenic silkworms to produce spider silk in commercial quantities.

Delivering biologics via oral administration represents a growing market that is expected to exhibit 35% CAGR from 2023–2028.

Biomanufacturers can avoid downstream detours if they are guided less by trial and error, and more by machine learning.

Knowledge extraction: Through the application of AI and knowledge graphs, Wisecube were able to explore repurposed drugs for ...

At GEN’s inaugural virtual summit on The State of AI in Drug Discovery, experts evaluated the evolution, opportunities, and ...

Enveda’s pipeline is led by ENV-294, a first-in-class, oral small molecule being developed to treat atopic dermatitis and other inflammatory conditions by combining the advantages of blockbuster drugs ...

Prostate cancer and other cancers characterized by “cold” tumors could become more responsive to checkpoint blockade if UBA1 is inhibited.

An analysis of fungi collected from peat bogs has identified several species that produce substances toxic to Mycobacterium tuberculosis (Mtb), the bacterium that causes tuberculosis in humans. The ...

Thaysen stepped in to lead Illumina through a tumultuous time, and now—as this GEN interview relates—he is carrying out his near- and long-term plans for the company.

SmartLabs’ new Custom Developed Solutions (CDS) platform provides specialized oversight and hands-on expertise in the design, ...

The CRISPR-SCD trial is the first clinical attempt to use a non-viral delivery approach to directly correct the sickle cell ...